Hematology Market Share, Growth, Trends & Forecast to 2027
The study, diagnosis, and treatment of blood and blood-related illnesses are all topics covered by the branch of medicine known as haematology. White blood cells, red blood cells, bone marrow, lymph, and platelets are all affected by haematology issues. It also has an impact on plasma, the known liquid component of blood. Anemia, leukaemia, myelofibrosis, blood transfusion, malignant lymphomas, and bone marrow stem cell transplantation are a few of the blood-related disorders. Hematology Market is divided into four main subspecialties: haematological malignancies, hemoglobinopathies, coagulopathies, and anaemia. Different IVD technologies, including flow cytometry, blood analysis, molecular diagnostics, immunodiagnostics, hemostasis, histology, and cytology, are included in the field of haematology.
Increasing incidence of blood related disorders is expected to propel the growth of the global Hematology Market. Rising incidence of blood cancer is a major factor contributing to growth of the market. For instance, according to GLOBOCAN 2018, more than 1.85 million new blood cancer cases are expected to be diagnosed in 2040 across the globe. Furthermore, according to the American Cancer Society, Non Hodgkin lymphoma is one of the more common types of cancer in the U.S., accounting for 4% of all cancer cases. An estimated 74,680 patients were diagnosed with Non Hodgkin lymphoma in the U.S. in 2018.
The Global Hematology Market Size is valued at US$ 4537.5 million in 2019, and is expected to exhibit a CAGR of 7.80% over the forecast period (2019–2027). The prevalence of haemophilia and sickle-cell anaemia is also anticipated to rise, propelling the expansion of the worldwide haematology market. For instance, the World Federation of Hemophilia (WFH) reported in 2018 that there were approximately 440,000 haemophiliacs worldwide, of which approximately 173,000 had haemophilia A or B. Additionally, according to the World Health Organization, anaemia prevalence among children was around 45% in 2018 and 12% among males. This prevalence is rising quickly across the globe. Similarly, anaemia affects 40% of pregnant women and 30% of women of reproductive age worldwide, according to the National Institutes of Health (NIH).
Comments
Post a Comment